Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a revised press release dated December 10, 2021, titled "SPARC to present updated clinical data of vodobatinib (SCO-088) at the 63rd ASH annual meeting".
Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a revised press release dated December 10, 2021, titled "SPARC to present updated clinical data of vodobatinib (SCO-088) at the 63rd ASH annual meeting".